Physician profile
Ryan A Boeck
NPI 1013182955
$6,135.92
in general payments reported to CMS, 2019-2025
41 companies · $1,177 in 2025
The $1,177 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $509 · 2021: $523 · 2022: $604 · 2023: $962 · 2024: $813 · 2025: $1,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $728.12 | 2019-2025 | Qelbree, Qelbree |
| Corium, LLC | $662.81 | 2021-2025 | Azstarys |
| Tris Pharma INC | $636.67 | 2019-2025 | Dyanavel Xr |
| Sk Life Science, INC. | $572.18 | 2020-2025 | |
| Ucb, INC. | $526.74 | 2019-2025 | Briviact, Nayzilam |
| Ironshore Pharmaceuticals INC. | $304.62 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $284.94 | 2019-2022 | |
| Greenwich Biosciences, INC. | $248.03 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $245.10 | 2019-2025 | Relexxii |
| Aquestive Therapeutics, INC. | $223.58 | 2019-2025 | |
| Neos Therapeutics, Lp | $180.67 | 2019-2025 | Cotempla Xr-Odt |
| Sunovion Pharmaceuticals INC. | $173.08 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $146.89 | 2019-2025 | |
| Neurelis, INC. | $93.20 | 2020-2024 | Valtoco |
| Noven Therapeutics, LLC | $75.43 | 2024-2025 | Xelstrym |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Boeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.